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Structural and biophysical studies on two promoter recognition
domains of the extra-cytoplasmic function σ factor σC from
Mycobacterium tuberculosis
Krishan Gopal Thakur, Anagha Madhusudan Joshi, and B. Gopal
Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India
Summary
σ factors are transcriptional regulatory proteins that bind to the RNA polymerase and dictate gene
expression. The extracytoplasmic function σ factors (ECF) govern the environment dependent
regulation of transcription. ECF σ factors have two domains σ2 and σ4 that recognize the −10 and
−35 promoter elements. However, unlike the primary σ factor σA, the ECF σ factors lack σ3, a region
that helps in the recognition of the extended −10 element and σ1.1, a domain involved in the auto-
inhibition of σA in the absence of core RNA polymerase. Mycobacterium tuberculosis σC is an ECF
σ factor that is essential for the pathogenesis and virulence of M. tuberculosis in the mouse and guinea
pig models of infection. However, unlike other ECF σ factors, σC does not appear to have a regulatory
anti-σ factor located in the same operon. We also note that Mycobacterium tuberculosis σC differs
from the canonical ECF σ factors as it has an N-terminal domain comprising of 126 amino acids that
precedes the σC2 and σC4 domains. In an effort to understand the regulatory mechanism of this protein,
the crystal structures of the σC2 and σC4 domains of σC were determined. These promoter recognition
domains are structurally similar to the corresponding domains of σA despite the low sequence
similarity. Fluorescence experiments using the intrinsic tryptophan residues of σC2 as well as surface
plasmon resonance measurements reveal that the σC2 and σC4 domains interact with each other.
Mutational analysis suggests that the Pribnow box binding region of σC2 is involved in this inter-
domain interaction. Interaction between the promoter recognition domains in M. tuberculosis σC are
thus likely to regulate the activity of this protein even in the absence of an anti-σ factor.
Introduction
The slow growing pathogen, Mycobacterium tuberculosis, has only one ribosomal RNA
operon. An efficient transcription mechanism is thus essential for the survival and
pathogenecity of this bacillus. Although a third of the human population are carriers of this
pathogen, only a few contract this disease. This bacillus can lie latent in the host for prolonged
periods of time till a mycobacterial infection gets triggered, most often in the setting of
decreased host immunity. Studies that help further our understanding of the latent phase of this
bacillus are thus vital to understand the mechanisms of pathogenesis and virulence in this
organism. This ability of M. tuberculosis to survive in the hostile environmental conditions in
the carrier is brought about by adaptability to rapidly changing environmental conditions. The
survival mechanism is thus crucially dependent on efficient communication between the
mechanism that senses the environment and the molecules that regulate transcription.
The DNA dependent RNA polymerase (RNAP) that controls gene expression consists of five
domains- two α subunits, one ω subunit and the β and β′ domains. The σ-factor reversibly
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associates with the RNAP and provides the RNAP enzyme with the ability to recognize
promoter regions on the DNA template. M. tuberculosis has a total of 13 σ-factors: 3 primary
σ factors and 10 extra-cytoplasmic function (ECF) σ factors. Differences in the promoter
specificity of these σ factors lead to differential gene expression (1,2). The task of environment-
dependent transcription modulation is performed by the ECF σ factors. Regulatory
mechanisms, in turn, dictate which σ factors get activated to bind to the apo-RNAP and initiate
transcription and which ones are not. This regulatory mechanism is coupled to a signal
transduction system that senses the environment. The interplay between signal transduction
and the transcriptional regulatory mechanisms allows the bacillus to respond to changes in the
environment by synthesizing new proteins or down-regulating others.
Studies on the transcription mechanism in E. coli have shown that a σ factor directs promoter-
specific transcription initiation by specific interactions between two hexamers of a consensus
DNA sequence- the Pribnow box (−10 element) and the −35 element. The crystal structure and
limited proteolysis experiments on the principal σ factor σA revealed a structural arrangement
comprising of a series of domains connected by flexible linkers. The utility of this structural
arrangement is borne out by the observation that substantial structural rearrangements take
place in the σ-factor during transcription initiation. Exposed surfaces of each of these domains
were found to be important for RNAP binding (3). Interaction with the core RNAP has been
demonstrated to structurally rearrange the σ factor into an active conformation in which the
DNA binding regions of σ2 and σ4 domains are exposed and appropriately positioned to
recognize the −10 and −35 elements (3,4,5,6).
Two distinct types of mechanisms have been proposed to describe the regulation of the activity
of the σ factors that belong to the σ70 family. Thus while auto-inhibition by the N-terminal
domain mediates the activity of the principal σ factor, σA, protein-protein interactions mediated
by the anti- and anti-anti-σ factors control σ factor concentrations in the case of the ECF σ
factors. Other regulatory mechanisms have been proposed wherein σ factor activity is
controlled by stimulatory signals (such as the phosphorylation and dephosphorylation
processes controlled by the kinases and phosphatases) or mechanisms that can control the
intracellular σ factor concentration by localizing it on the inner surface of the cell membrane.
In the case of the E. coli σ factor σE (7) for example, many of the key regulators of σE activities
(products of the rse genes) are co-transcribed with RpoE to form an operon : rpoE, rseA, rseB
and rseC. The protein RseA is an anti-σ factor for σE whereas the periplasmic RseB protein
enhances its activity. The activity of σE can also be regulated by cytoplasmic factors like
guanosine 3′,5′-bispyrophosphate (ppGpp). The signaling pathway employed in this process
is distinct from the pathway that is activated upon extra-cytoplasmic stress (8). Very little is
known of these processes in mycobacteria although recent reports indicate that work to
delineate the regulatory mechanism of σE and another σE-like factor σH are presently in
progress (9,10,11). The anti-σ factor, as seen in the cases of the SpoIIAB (12) and the σE-RseA
complex (4), appears to bind the free σ factor, thereby preventing its interaction with the core
RNAP. The σ28/FlgM complex (6) on the other hand is different from the others in that FlgM
can also form a ternary complex with the σ28 holoenzyme, thereby destabilizing the σ28/RNAP
interaction. The modes of σ factor anti-σ factor interactions also differ between the σ70 and
σ28 families. The anti-σ factor RseA is sandwiched between σE2 and σE4 domains of σE whereas
the FlgM protein wraps around the outside of σ28 and occludes the core RNAP binding
determinants on σ282 and σ284
M. tuberculosis has about 190 transcription regulators (13) which include 13 σ factors, 11 two-
component systems, 5 unpaired response regulators, 11 protein kinases and 140 other proteins.
The resulting interaction amongst these proteins suggests a complex system of overlapping
functions and redundancies (9). Four σ factors, σA, σB, σC and σE of the 13 in M.
tuberculosis are conserved in all the pathogenic mycobacteria. Only four σ factors in M.
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tuberculosis σA, σC, σD and σL have been examined in detail for their roles in virulence and
pathogenecity. The ECF σ factor σC is essential for lethality in mice but is not required for
bacterial survival in this species (14). Based on genomic microarray data, σC was demonstrated
to modulate the expression of several key virulence associated genes including hspX, senX3
and mtrA, a two component sensor kinase and a two component response regulator. The
phenotype of the Δ σC mutant of M. tuberculosis can thus persist in tissues but is attenuated in
its ability to elicit lethal immunopathology (14). A recent report also suggests σC to be a key
regulator of pathogenesis and adaptive survival in the lung and spleen of guinea pigs (15).
These in vivo studies in two different animal models thus demonstrate the role of σC in the
pathogenesis and virulence of M. tuberculosis. Although σC does not appear to have an anti-
σ factor located in the same operon, in silico analysis for the identification of potential
interacting partners for σC suggested two proteins SirR and the unannotated protein Rv0093c.
However, the interaction between these proteins and σC could not be substantiated by
experimental evidence.
In this manuscript, we report the biochemical and structural analysis of the domain organization
of σC. Despite the low sequence similarity between the promoter recognition domains of σC
with the primary σ-factor σA, we observe that the crystal structure of the two promoter
recognition domains are conserved. Spectroscopic studies using the intrinsic tryptophan
fluorescence as well as surface plasmon resonance experiments suggest that the σC2 and σC4
domains interact in vitro. Interactions between the two promoter recognition domains of σC
which involves the occlusion of the Pribnow box recognition region of σC2 suggests that
substantial inter- domain rearrangements would be needed to activate σC even in the absence
of an anti σ-factor.
Methods
Cloning, Expression and Purification of σC, and the σC2 and σC4 domains
The details of the expression constructs used in this study are compiled in Table 1. After
transforming the plasmid into BL21 (DE3) or Rosetta origami cells (Novagen, Inc.), the cells
were grown in Luria broth with an antibiotic selection (ampicillin 100 μg/ml and
chloramphenicol 30 μg/ml) to an OD600 nm of 0.5-0.6. The cells were induced with 0.2 mM
IPTG (final concentration). Subsequently, the growth temperature was lowered to 290 K and
cells were grown for further 12-18 hrs before they were spun down and stored at 193 K. Full
length σC (311 amino acids) was purified in denaturing conditions using 8M urea. Refolding
of the denatured protein was carried out in a step-wise fashion with five buffer changes (each
lasting about 3-4 hours) with decreasing concentration of urea. The recombinant proteins from
the other three constructs were purified under native conditions as described earlier (16). The
proteins were further purified by size exclusion chromatography using a Superdex S-200
column (Amersham-Pharmacia, Inc.) after the affinity chromatography step. The proteins were
concentrated using membrane based centrifugal ultra filtration (Amicon). L-Arginine and L-
glutamic acid were added to the final concentration of 50mM each during the concentration
step (17). The purity of the samples was analyzed using SDS-PAGE followed by Coomassie
blue staining. Both full length σC as well as the σC4 domain have poor solubility and are very
unstable. These proteins were freshly purified prior to each biochemical experiment. The
molecular weights of the recombinant proteins were also verified by Mass spectrometry on a
MALDI-TOF (Bruker Daltonics, Inc) mass spectrometer.
The western blot analysis to determine the molecular weight of σC  in situ was performed
according to the standard ocedure outlined in Molecular Cloning (18). Cell free lysate of H37Rv
was obtained from the TB vaccine testing and research material contract at the Colorado state
University. The cell lysate and purified protein samples were resolved in 10% SDS-PAGE,
and transferred to a nitrocellulose membrane. A polyclonal antibody raised in rabbit against
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σC127-311 (a smaller construct containing residues 127-311aa based on the annotated sequence
of H37Rv) was used as the primary antibody for σC detection. Western blots were developed
using the AEC (Sigma-Aldrich, Inc.) substrate with HRP-labeled sheep anti-rabbit IgG
(Bangalore Genei Co.)
Site directed mutagenesis experiments were performed using a PCR based method (19). The
primers GATAGGCGACGAACCGCGCCACGTCTTGCTGGG (for W164A) and
CGATGGCCAGCAACGCAGTTCGGGCGCTGG (for the W203A point variant) were used.
These mutations were confirmed by DNA sequencing.
Fluorescence Spectroscopy
All fluorescence studies were performed on a JOBIN YVON FlouroMax-3 fluorimeter at room
temperature. The fluorescence excitation was set at 280 nm and emission spectra were recorded
from 300 to 400 nm at a band-width of 1 nm. The excitation and emission slit widths were set
to 3 and 5 nm, respectively. Each spectrum is an average of five scans. The spectra were
obtained at a protein concentration of ∼ 3 μM in 10 mM Tris-HCl, 50 mM NaCl pH 7.5.
Interactions between the σC2 and σC4 domains were monitored after the two protein samples
were mixed and incubated at room temperature for 2 minutes prior to data acquisition.
Surface Plasmon Resonance Experiments
Surface plasmon resonance (SPR) assays were performed on a BIAcore 2000 instrument
(BIAcore AB). All experiments were conducted at 25°C. SPR experiments were performed
with either the σC2 and σC4 domains immobilized onto carboxylated dextran chips (sensor chip
CM5 from BIAcore AB) using the standard amine coupling procedure as recommended by the
manufacturer. Immobilization resulted in a change in the refractive index corresponding to 700
and 640 resonance units (RU) for σC2 and σC4 respectively. Binding and kinetic assays were
performed in 50 mM sodium phosphate (pH 7.4), 100 mM NaCl at flow rate of 20 μL/min.
The proteins were diluted in this buffer and experiments were carried out at concentrations
ranging from 0.8–200 μM. Freshly purified protein samples were used for these binding assays.
Dissociation was initiated by replacing the analyte with buffer. The association and dissociation
curves were monitored for 120s. Sensograms were analyzed with BIAevaluation software
version 2 (BIAcore AB). A 1:1 langmuir binding model was used to fit the curves.
Model building and Refinement of the two domains of σC
Crystallization conditions and data collection strategies have been reported previously (16).
The data collection and refinement statistics for both the domains are reported in Table 2. The
N- and C-terminal domains of E.coli σE (PDB code 1OR7) were used as starting model(s) for
Molecular Replacement (MR). The sequence identity between σC2 and N-term σE is 23%
whereas that between the C-term σE and σC4 domain is 45%. MR calculations were performed
using the program PHASER(20). The solution for σC2 and σC4 had log likelihood gains of
71.52 and 489.97 with corresponding Z-scores of 5.21 and 15.53 respectively. There were two
molecules in the asymmetric unit in the case of σC2 and three in the asymmetric unit for the
σC4 domain. Both structures were refined using tight non-crystallographic symmetry (NCS)
restraints. Iterated cycles of model building using Coot (21) and refinement using Refmac
(22) led to the final model for σC2 with an Rcryst of 18.9% and Rfree of 24.3%. The final model
σC4 had Rcryst of 21.0 % and Rfree of 26.7% The final model of σC2 consists of 88 residues, 4
sulfate ions and 20 water molecules whereas that for the σC4 domain has 60 residues, 8 sulfate
ions and 17 water molecules.
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Computational strategies to identify potential σC interacting proteins
In M. tuberculosis the following σ-anti σ pairs have been reported: σD-Rv3413c, σE-Rv1222,
σF-Rv3287c, σH-Rv3222c and σL-Rv0736 (23,24,25,26,27). σD, σF, σH and their respective
anti-σ factors are canonical in the sense that these pairs occur as a part of one operon. σC the
only member in an operon in both the M. tuberculosis strains H37Rv and CDC1551. Assuming
that interacting proteins would show correlated expression levels under certain conditions, the
correlation coefficients and t values (Student's t test) between a given σ factor and the
corresponding anti-σ pair were calculated in different conditions (7H9 medium(N=4), Balb
mice(N=4), Scid mice(N=4), stationary state(N=6), Low oxygen dormancy(N=9) using the
equations given below:
rjk = (∑ (xij − X− j)(xik − X−k)) ∕ nσjσk
= (∑ (xij − X− j)(xik − X−k)) ∕ ((∑ (xij − X− j)2)(∑ (xik − X−k)2))1∕2
tjk = rjk(N − 2)1∕2 ∕ (1 − rjk2)1∕2
To predict all the interacting proteins/anti-σ factor(s) for σC, we examined all the transcription
regulatory genes that are present in M. leprae (M. Leprae has only 4 σ factors σA, σB, σC, and
σE). An amino-acid sequence based search was also performed to locate putative anti-σ factors
on the basis of the sequence signature (HXXXCXXC) (27). Transmembrane protein prediction
was done using the program Conpred (28). These results are compiled in Supplementary Table
1.
Results and Discussion
Characterization of the domain organization of M. tuberculosis σC
Differences in the annotation of σC in the two M. tuberculosis strains H37Rv (13) and CDC1551
(29) led to the identification of an N-terminal 126 residue long polypeptide preceding the
structured domain σC2. The σC2 and σC4 domains are connected by a flexible ∼25 amino acids
long linker. Sequence based prediction of low complexity regions (30) in this protein (Figure
1a) suggests that the N-terminal domain preceding σC2 is largely unfolded. M. tuberculosis
extra-cytoplasmic σC thus appears to be more primary σ factor-like in terms of the domain
organization except that it lacks the region 3.2 that lies between the σC2 and σC4 domains and
is involved in extended −10 promoter recognition. The sequence based structure alignment of
M. tuberculosis σC is shown in Figure 2 (adapted from reference 2). Interestingly,
Myobacterium leprae σC does not have this N-terminal region. Based on the sequence
alignment and patterns of protease sensitivity, four expression constructs of σC were examined:
the full length σC, the smaller construct containing only the σC2 and σC4 domains and the two
independent domains σC2 and σC4 (Table 1 and Figure 3). In a western blot experiment using
cell free lysate of M. tuberculosis H37Rv (obtained from the TB research center, Colorado
State University), the polyconal antibody raised against the shorter length construct (lacking
the 126 amino acid polypeptide at the N-terminus) recognized the full-length σC. σC is thus a
311 amino acids long protein in both the laboratory (H37Rv) as well as the clinical (CDC1551)
strains of M. tuberculosis (Figure 3).
Structure determination of the σC2 and the σC4 domains
The σE2 and σE4 domains of E. coli σE were used as search models to solve the structures of
M. tuberculosis σC2 and σC4 domains by Molecular Replacement. Overall, these two proteins
have 32 % identity in the amino acid sequence although the C-terminal region is more
conserved than the N-terminal polypeptide. Thus while M. tuberculosis σC2 and E. coli σE2
have 23 % identity, M. tuberculosis σC4 and E. coli σE4 are more similar with ∼ 44 % sequence
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identity. The crystallization of the σC2 and the σC4 domains has been reported earlier (16). The
data collection and refinement statistics are compiled in Table 2 (more details in Supplementary
Figure 1). Despite the low sequence similarity, the overall topology of the σC2 and the σC4
domains is similar to that of the known σ factors reported till date (3,4,5,6). The backbone
Cα superposition between σC2 with E. coli σA2 shows a root-mean-squared-deviation (rmsd)
of 2.97 Å (∼8 % identity over 77 amino acid residues) whereas σC2 superposes better with E.
coli E2 with an rmsd of 1.4 Å (24 % identity over 88 residues). The σC4 domain which interacts
with the −35 promoter element is structurally more conserved with a backbone rmsd of 1.6 Å
with the corresponding domain of the primary σ-factor σA4. Molecular modeling and docking
based on the structure of the Thermus aquaticus RNAP suggests that the σC2 and σC4 domains
would be spatially separated by a distance of ∼50 Å (data not shown) when bound to the RNAP.
This distance is compatible with the ca 25 residue linker joining the σC2 and σC4 domains.
Studies on the primary σ-factor σA have shown that aromatic and charged residues in region
2 are involved in recognizing the −10 element and subsequent strand separation (31). On the
basis of multiple sequence alignment, W203 was found to be universally conserved and is
likely to be involved in interactions with the Pribnow box element. Based on a model of E.
coli σE-holoenzyme and the σE-RseA structure (4), Campbell et al proposed that the E. coli
anti-σ factor RseA functions by sterically occluding the two primary RNAP-binding regions
on σE. Activation of the σE regulon occurs when σE is released from RseA upon degradation
by the Hho (DegS) protease. In the σE-RseA structure, the anti-σ factor was found to be
sandwiched between the σE2 and the σE4 domains. Several substitutions in E. coli σE4, R178G,
I181A and V185A were identified as those that led to defective RseA binding (4). In the case
of M. tuberculosis, the equivalent Arg residue is conserved whereas the other two positions
(E. coli/M. tub) are replaced by (Ile/Leu) and (Val/Ala).
Identification and verification of potential σC interacting proteins in M. tuberculosis
M. tuberculosis σC is different from other ECF σ factors as there is no anti-σ factor located
downstream of σC in the same operon. To understand the mechanism of regulation of
transcription by σC, attempts were made to identify the interacting partners that could activate/
inactivate this protein. Coimmunoprecipitation using the purified σC antibody using the cell
free lysate (obtained from the TB research center, Colorado State University) was used to
isolate proteins that interact with σC. These proteins were identified by in situ digestion using
trypsin followed by peptide mass-fingerprinting using a MALDI-TOF mass spectrometer and
analyzed using MASCOT (Bruker Daltonics, Inc). Few components of RNAP could be
detected at high confidence levels (data not shown). However, no potential anti-σ factor could
be identified in this experiment. Several computational tools were also used to identify proteins
that could potentially interact with σC. These results including relevant entries from the
database STRING (32) are compiled in Table 3. The application of this tool for the prediction
of protein–protein interactions suffers from the problem that functional interaction does not
necessarily imply direct physical interaction. Based on the co-occurrence of genes in related
species, proteins exhibiting similar phylogenetic profiles can be predicted to be functionally
linked i.e. they occur as a structural complex or are involved in a common metabolic pathway.
Although 29 potential interacting proteins could be identified using this approach, none showed
a significant correlation in their mRNA expression levels with that of σC. The Rosetta tool for
gene fusion analysis (33) led to the identification of the gene Rv0093c. In this method the
existence of a fusion protein in one genome allows the prediction of the interaction between
the single domain proteins in other genomes. Rv0093c also has an amino-acid sequence
signature proposed for anti-σ factors that regulate oxidative stress (27) and a conditional
correlation was observed between the expression level of this protein versus σC in one DNA
microarray data-set. A pertinent observation in this regard is that notwithstanding the large
errors involved in the gene expression levels obtained using DNA microarray technology, well
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characterized σ-anti σ pairs exhibit significant correlation (α=0.05) under specific
environmental or growth conditions (Table 3b).
A sequence based search for RseA-like proteins in the M. tuberculosis genome led to the
identification of a protein SirR (32 % identity between the E. coli RseA sequence that interacts
with σE and M. tuberculosis SirR). The annotation of SirR in the M. tuberculosis genome
describes it as an Iron dependent transcription repressor. Two strategies, one involving co-
expression using pET-Duet1 vector and the other by in vitro studies using purified recombinant
proteins were adopted to examine interactions between σC and the predicted anti-σ factors SirR
and Rv0093c. In the co-expression approach, σC was cloned with a poly-histidine tag at the
N-terminus to enable the complex to be purified by affinity chromatography. No interaction
could be detected between either of these proteins and σC  in vitro (data not shown). This
finding could probably be rationalized on the basis of the variations seen in residues that are
involved in RseA recognition.
Interaction between the two promoter recognition domains σC2 and σC4
Fluorescence measurements using the intrinsic tryptophan residue in σC2 were used to monitor
the interactions between the two promoter recognizing domains of σC. The fluorescence spectra
are shown in Figure 4. There are two tryptophans in σC2 (region 2) and none in σC4 (region 4)
(Figure 4b). This fortuitous distribution of tryptophan residues helped us examine the
interactions between the σC2 and σC4 domains. A fluorescence spectrum of native σC (127-311
residues) showed an emission maximum at 342 nm while σC2 showed an emission maximum
at 349 nm. Upon the addition of σC4 in stoichiometric ratio, a blue shift (∼7nm) in the
fluorescence spectrum was observed with a reduction in the emission intensity. A
representative binding reaction wherein the σC4 domain is titrated into the σC2 domain is shown
in Figure 4a. This fluorescence titration suggests a weak interaction between the σC4 and
σC2 domains (Kd ∼ 2 μM).
Of the two tryptophans in σC2, Trp-203 is involved in DNA melting (Pribnow Box element).
Based on molecular modeling analysis (data not shown) Trp-164 is likely to interact with the
RNAP. These observations led us to investigate the specificity of interactions (given the fact
that the two domains are connected by a flexible linker of ca 25 amino acids long) and identify
the region where σC4 binds σC2. To address these questions, two point variants of σC  viz
W164A and W203A were constructed in σC127-311 (medium length σC that lacks the positively
charged N terminal domain which contains three tryptophan residues). The W164A mutant
protein had a fluorescence emission maximum at 335 nm whereas the W203A variant had its
emission maximum at 353 nm (Figure 4b). The blue shift seen in the W164A variant suggests
that σC4 interacts σC2 in the region that would lead to the partial burial of W203 (Figure 4c).
Interactions between the σC2 and σC4 domains thus result in the occlusion of the Pribnow box
recognition element.
The interaction between the σC2 and σC4 domains was also monitored by Surface Plasmon
Resonance experiments (Figure 4d). SPR studies of the interaction between the σC2 and σC4
domains suggest a low affinity binding between these two domains (Kd=1.81±0.03μM). The
binding affinity and kinetic parameters were comparable when either the σC2 and σC4 domain
was immobilized. The highly polar nature of this interdomain interaction was apparent from a
size exclusion chromatography experiment performed at medium salt concentrations (250mM
NaCl) where the two domains migrate separately. This was also supported by fluorescence
quenching experiments where increasing salt concentrations not only reduced the fluorescence
quenching but also resulted in a red shift in the emission maximum (Supplementary Figure 3).
In summary, the structural and biophysical studies on the two promoter recognition domains
of σC shows an interaction between the σC2 and σC4 domains that is mostly governed by polar
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residues. This interaction involves the occlusion of the region of σC that participates in the
recognition of the −10 promoter element. The binding of M. tuberculosis σC to the core RNAP
would thus involve substantial structural re-arrangement to release σC from its auto-inhibited
state. These observations thus provide an alternate mechanism for the regulation of the ECF
σ-factor, σC.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Domain Organization of M. tuberculosis σC. (A) Estimate of the folded nature of the three
domains of σC calculated using the program FoldIndex (30). These estimates are consistent
with presently available biochemical data on the principal σ factor σA. The top panel shows
the pI of different domains in σC. (B) Molecular surface representation of the two domains of
σC. Residues that interact with the −10 promoter element (σC2) and the −35 element (σC2) are
highlighted in a ball-and-stick representation. These two domains are connected by a flexible
linker.
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Figure 2.
Structure based sequence alignment of σ70  families of σfactors. The top three sequences
correspond to those of the principal σ factors with the secondary elements that correspond to
the T. aquaticus σA (3). The two sequences below those of the principal σ factors correspond
to ECF σ factors. The secondary structure representation in this case is based on M.
tuberculosis σC. Regions of the σ factor that have been implicated in promoter recognition are
highlighted. The residues crucial for the interactions with RseA in case of E. coli σE are shown
in red. The abbreviations are: MtbC: M. tuberculosis σC, MtbA: M. tuberculosis σA, EcolA:
E. coli σA, EcolE: E. coli σE, TaqA: T. aquaticus σA.
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Figure 3.
M. tuberculosis σC has an N-terminal polypeptide preceding the σC2 and σC4 domains.
(A) Western blot analysis using the cell free lysate of M. tuberculosis H37Rv. The size of the
protein corresponds to that of the full-length 311 residue protein of σC. Lane 1:prestained
protein marker, lane 2: M. tuberculosis H37RV cell free lysate, lane 3:purified σC1-311aa  (B)
12% SDS PAGE gel showing different constructs used in the present study. Lane 1: protein
marker, lane 2: σC1-311aa (35.3KDa), lane 3: σC127-311aa (22.5KDa), lane 4: σC 2 (14.7KDa),
lane 5: σC 4 (9.5KDa). The details of these expression constructs are given in Table 1.
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Figure 4.
The σC2 and σC4 domains of σC interact with each other in the absence of core RNA
polymerase. A. Interaction between the σC2 and σC4 domains monitored by the Fluorescence
spectroscopy. In this experiment the quenching of the intrinsic tryptophan flurescence was
monitored as a titration with increasing concentrations of the σC4 domain (that has no
tryptophan residues). This data was analyzed using the SigmaPlot software suite (Systat, Inc.).
B. Changes in the intrinsic tryptophan fluorescence suggests an interaction between the σC2
and σC4 domains. C. Spatial orientations of the two tryptophan and one tyrosine residues on
σC2. The probable site for interaction is shown with the circle. D. A representative SPR
sensogram that shows interactions between the σC2 and σC4 domains. In this experiment,
σC4 was immobilized on the CM-5 chip (Amersham-Pharmacia, Inc.) while the σC2 domain
was used as the analyte. The experiments were performed with different concentrations of
σC2.
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Table 1
List of Expression constructs used in the analysis of the domain organization of M. tuberculosis σC
S.No Construct Restriction sites used
5′ , 3′
Construct size
1 pET15b-σC127-311aa NdeI, BamHI 127-311aa
2 pET15b-σC2 NheI, XhoI 127-238aa
3 pET15b-σC4 NdeI, BamHI 243-311aa
5 pETduet1-σC EcoRI, HindIII 1-311aa
6 pETduet-σC-Rv0093c EcoRI, HindIII; Nde1-Xho1 127-311; 1-95
7 pETduet-σC-SirR EcoRI, HindIII; Nde1-Kpn1 127-311; 88-149
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Table 2
Summary of data collection, processing and refinement statistics
σC2 σC4
Wavelength (Å) 1.54 1.54
Resolution (Å) 35.01-2.70 (2.89-2.70) 40.29-3.0 (3.16-3.0)
Number of reflections 45969 (6060) 23915 (2920)
Number of unique reflections 17709 (2612) 7040 (1002)
Completeness 99.8 (99.2) 99.4 (97.9)
Redundancy 2.6 (2.3) 3.4 (2.9)
Rsym 0.087 (0.387) 0.105 (0.546)
I/σ 10.9 (2.3) 11.1 (2.0)
Rcryst 20.1 (26.0) 20.8 (33.8)
Rfree 24.7 (24.7) 26.4 (33.2)
a
Values for outer shells are given in paranthesis.
b
Rsym=Σj|<I>-Ij|/Σ<I> where Ij is the intensity of the jth reflection and <I> is the average intensity.
c
Rcryst=Σhkl|Fo – Fc|/Σhkl|Fo|
d
Rfree was calculated as for Rcryst but on 5 % of the data excluded from the refinement calculation.
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